Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ALXN
Earnings Scheduled For October 26, 2017
Is A Beat In Store For Alexion This Earnings Season?
Tracking John Paulson's Paulson & Company Portfolio - Q3 2017 Update (Seeking Alpha)
Related DHR
BMO: Here's What Sets Fortive Apart From Other Industrials
Lightning Round: Jim Cramer Weighs In On Wendys, Aetna And More
Aristotle Capital Management, LLC Buys DowDuPont Inc, Capital One Financial Corp, Danaher Corp, ... (GuruFocus)

Analysts at Citigroup initiated coverage on shares of Alexion Pharmaceuticals (NASDAQ: ALXN) with a “neutral” rating. Alexion's shares closed at $93.59 yesterday. Alexion's trailing-twelve-month operating margin is 35.20%.

BMO Capital initiated coverage on shares of Danaher (NYSE: DHR) with an “outperform” rating. Danaher's shares closed at $53.07 yesterday. Danaher's trailing-twelve-month revenue is $18.00 billion.

SunTrust initiated coverage on shares of Citigroup (NYSE: C) with a “buy” rating. Citigroup's stock closed at $37.02 yesterday. Citigroup had $798.78 billion in total cash for the recent quarter.

Analysts at Wedbush initiated coverage on shares of Oracle (NASDAQ: ORCL) with a “neutral” rating. Oracle's shares closed at $32.03 yesterday. Oracle's PEG ratio is 1.00.

Latest Ratings for ALXN

DateFirmActionFromTo
Oct 2017Stifel NicolausMaintainsBuy
Oct 2017PiperJaffrayAssumesOverweightOverweight
Sep 2017RBC CapitalInitiates Coverage OnOutperform

View More Analyst Ratings for ALXN
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ALXN + C)

View Comments and Join the Discussion!

Partner Center